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Abstract 
Background: The coronavirus disease-19 (COVID-19) pandemic had a relatively minimal direct impact on critical 
illness in children compared to adults. However, children and paediatric intensive care units (PICUs) were affected 
indirectly. We analysed the impact of the pandemic on PICU admission patterns and patient characteristics in the UK 
and Ireland.
Methods: We performed a retrospective cohort study of all admissions to PICUs in children < 18 years during Jan–
Dec 2020, using data collected from 32 PICUs via a central database (PICANet). Admission patterns, case-mix, resource 
use, and outcomes were compared with the four preceding years (2016–2019) based on the date of admission.
Results: There were 16,941 admissions in 2020 compared to an annual average of 20,643 (range 20,340–20,868) from 
2016 to 2019. During 2020, there was a reduction in all PICU admissions (18%), unplanned admissions (20%), planned 
admissions (15%), and bed days (25%). There was a 41% reduction in respiratory admissions, and a 60% reduction in 
children admitted with bronchiolitis but an 84% increase in admissions for diabetic ketoacidosis during 2020 com-
pared to the previous years. There were 420 admissions (2.4%) with either PIMS-TS or COVID-19 during 2020. Age and 
sex adjusted prevalence of unplanned PICU admission reduced from 79.7 (2016–2019) to 63.1 per 100,000 in 2020. 
Median probability of death [1.2 (0.5–3.4) vs. 1.2 (0.5–3.4) %], length of stay [2.3 (1.0–5.5) vs. 2.4 (1.0–5.7) days] and 
mortality rates [3.4 vs. 3.6%, (risk-adjusted OR 1.00 [0.91–1.11, p = 0.93])] were similar between 2016–2019 and 2020. 
There were 106 fewer in-PICU deaths in 2020 (n = 605) compared with 2016–2019 (n = 711).
Conclusions: The use of a high-quality international database allowed robust comparisons between admission 
data prior to and during the COVID-19 pandemic. A significant reduction in prevalence of unplanned admissions, 
respiratory diseases, and fewer child deaths in PICU observed may be related to the targeted COVID-19 public health 
interventions during the pandemic. However, analysis of wider and longer-term societal impact of the pandemic and 
public health interventions on physical and mental health of children is required.
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Background
Coronavirus disease (COVID-19) caused by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) dur-
ing this global pandemic has been rare in children com-
pared to adults [1]. The number of children requiring 
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paediatric intensive care unit (PICU) admission with 
either acute COVID-19, or related conditions such as the 
novel post-covid inflammatory syndrome referred to as 
paediatric inflammatory multisystem syndrome tempo-
rally associated with SARS-CoV-2 (PIMS-TS) or multi-
system inflammatory syndrome in children (MIS-C), was 
small in comparison with the number of adults requiring 
critical care admission following SARS-CoV-2 infection 
[2, 3]. Nonetheless, the pandemic affected critically ill 
children and PICUs in many other ways [4].
Several PICUs were either entirely or partially repur-
posed to provide adult critical care [5]. During the crisis 
most institutions reduced their planned surgical activity. 
However, changes to the pattern of emergency admis-
sions to PICU have also been observed [6–8]. To date, 
however, there have been no national population–level 
reports describing the impact of the pandemic and the 
‘lockdown’ periods during the whole of 2020 on criti-
cal care admissions in children. We aimed to analyse 
whether PICU activity in 2020 differed from the previous 
years across the whole of theUK and Republic of Ireland 
(RoI) using the paediatric intensive care audit network 
(PICANet) database. In particular, we aimed to analyse 
the nature and magnitude of differences in admissions, 
bed-activity, case-mix, interventions, and outcomes of 
PICU admissions during 2020, compared with preceding 
years.
Methods
We performed a retrospective analysis of routinely col-
lected information for all admissions to PICUs in chil-
dren less than 18 years of age from all UK and RoI PICUs 
(n = 32). Admission patterns, case-mix, resource use and 
outcomes during the initial pandemic year (2020) were 
compared with the four preceding years (2016–2019), 
based on the date of admission.
Data collection
Since 2002, PICANet has collected, analysed and 
reported information related to admissions from PICUs 
in England and Wales. Data collection was expanded over 
subsequent years to include PICUs in Scotland, Northern 
Ireland (NI) and the Republic of Ireland [9]. PICANet has 
a validated comprehensive database containing clinical 
and demographical information on over 300,000 PICU 
admissions and over 2 million bed-days. Data quality is 
maintained through central and local data validation as 
well as regular site visits. The admission dataset includes 
information related to patient demographics, diagno-
ses, interventions included in the paediatric critical care 
minimum dataset, and vital status at discharge from 
PICU, as well as severity of illness variables at the time of 
admission for calculation of the Paediatric Index of Mor-
tality-3 (PIM3) score [10].
Primary diagnoses, comorbidities and procedures are 
coded using Read Clinical terms version 3 codes. Diag-
nostic category was assigned on the basis of the primary 
diagnosis submitted to PICANet by the clinicians from 
the relevant PICUs. Specific diagnoses indicating the 
main reason for admission for conditions such as asthma, 
bronchiolitis and diabetic ketoacidosis (DKA) were 
extracted from the PIM3 part of the dataset. A planned 
admission, as defined by PICANet data manual avail-
able at www. pican et. org. uk, is an admission that could 
have been delayed for more than 24 h without risk or is 
a post-operative admission of which a PICU is aware of 
before the surgery begins. At the start of the pandemic, 
a customised dataset was established to collect informa-
tion about all children admitted to PICUs with diagnoses 
of COVID-19 and/or PIMS-TS. Age–sex adjusted preva-
lence estimates used mid-year population estimates for 
the most recent year of publicly available age–sex popu-
lation data for each country at the time of analysis (May 
2021) [11, 12].
Statistical analysis
Descriptive data are reported as numbers and percentage 
for categorical variables and medians with interquartile 
ranges (IQR) and mean ± standard deviations for con-
tinuous variables. Data collected from 2020 activity were 
compared with the 2016–2019 (‘pre-pandemic’) period. 
Absolute differences in proportion of patients (with 
95% confidence intervals), relative to overall number of 
admissions, as well as relative differences between 2020 
compared with 2016–2019 mean numbers are reported. 
In-PICU mortality was assessed using a multilevel logis-
tic regression model to account for any potential cluster-
ing at the PICU level with adjustment made for PIM3 
predicted probability of death. Statistical process control 
charts were used, if required, to highlight special cause 
variation, if any [13].
Ethics
Processing of personally identifiable data for the purposes 
of service evaluation, audit and research was approved by 
the Patient Information Advisory Group (now the Health 
Research Authority Confidentiality Advisory Group) in 
2002 under Section 60 of the Health and Social Care Act 
(subsequently Section  251 of the National Health Ser-
vice Act 2006) (reference: PIAG 4-07(c) 2002). This was 
amended and approved specifically to collect additional 
data relating to COVID-19 for confirmed and suspected 
cases.
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Results
Admissions and bed activity
During 2020, only 16,941 PICU admissions were 
observed compared to a mean of 20,643 (range 20,340–
20,868) per year over the period 2016–2019. This rep-
resents an 18% reduction in PICU admission numbers 
in 2020 compared to the mean of the pre-pandemic 
period (Table  1). There were fewer PICU bed-days in 
2020 with 109,216 bed-days recorded compared to 
a mean of 145,168 per year (range 140,836–147,985) 
during 2016–2019, representing a 25% reduction. 
The magnitude of reduction in PICU bed-days varied 
Table 1 Differences in PICU admissions, bed-days and diagnostic categories between 2020 and 2016–2019
PIM paediatric index of mortality, CVVH continuous veno-venous haemofiltration, ECLS extracorporeal life support, *denominator for percentage is number of 
unplanned admissions, †on any day of PICU admission
2016–2019 aggregate 2020 Comparison (2020 vs. 2016–2019)
Mean (range) n Absolute difference Relative difference 
(%)
Number of PICU admissions
January–March 5239 (5134–5319) 4846  − 393 7.5
April–June 5008 (4982–5059) 3393  − 1615 32.3
July–September 4869 (4788–4921) 4270  − 599 12.3
October–December 5527 (5326–5733) 4432  − 1095 19.8
Annual 20,643 (20,340–20,868) 16,941  − 3702 17.9
PICU bed days
January–March 37,541 (36,963–38,922) 31,122  − 6419 16.3
April–June 34,675 (32,823–35,965) 24,709  − 9966 28.7
July–September 33,593 (32,438–34,480) 28,851  − 4742 14.8
October–December 39,359 (32,248–40,980) 24,534  − 14,825 37.7
Annual 145,168 (140,836–147,985) 109,216  − 35,952 24.8
Median (IQR) Median (IQR) Difference in medians
PIM3 predicted probability of 
death
1.2 (0.5–3.4) 1.2 (0.5–3.4) 0.0





Planned 8275 (40.1) 7065 (41.7) 1.6 (0.8 to 2.4)  − 1210 (− 14.6)
Unplanned 12,364 (59.9) 9862 (58.2)  − 1.7 (− 2.4 to 0.9)  − 2502 (− 20.2)
Primary diagnosis/reason for PICU admission
Respiratory 6119 (29.6) 3601 (21.3)  − 8.3 (− 9.0 to − 7.6)  − 2518 (− 41.1)
Unplanned  respiratory* 5117 (41.4) 2922 (29.6)  − 11.8 (− 12.8 to − 10.8)  − 2195 (− 42.9)
Trauma 419 (2.0) 394 (2.3) 0.3 ( 0.1 to 0.5)  − 25 (− 6.0)
Diabetic ketoacidosis 142 (0.7) 261 (1.5) 0.8 ( 0.6 to 1.0)  + 119 (+ 83.8)
Asthma 399 (1.9) 239 (0.7)  − 1.2 (− 1.4 to − 1.1)  − 160 (− 40.1)
Bronchiolitis 1820 (8.8) 726 (4.3)  − 4.5 (− 4.9 to − 4.2)  − 1094 (− 60.1)
Interventions
Invasive  ventilation† 12,757 (61.8) 9999 (59.0)  − 2.8 (− 3.6 to − 2.0)  − 2758 (− 21.6)
Inhaled nitric oxide 808 (3.9) 641 (3.8)  − 0.1 (− 0.4 to 0.2)  − 167 (− 20.6)
CVVH 369 (1.8) 335 (2.0) 0.2 (0.0 to 0.4) –34 (− 9.2)
ECLS 249 (1.2) 205 (1.2) 0.0 (− 0.2 to 0.2)  − 44 (–17.7)
Outcomes
In-PICU mortality 711 (3.4) 605 (3.6)  − 0.2 (− 0.5 to 0.1) –106 (− 14.9)
In-PICU mortality for respiratory 
admissions
134 (2.2%) 67 (1.9%) 0.3 (− 0.2 to 0.8)  − 67 (− 50.0)
Median length of stay (days) 2.3 (1.0–5.5) 2.4 (1.0–5.7) 0.1
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between the countries, with a 12% reduction in RoI 
to 31% in Scotland. Notably, there were 32% fewer 
PICU admissions during the first period of ‘lockdown’ 
(April–June 2020) [14], and 20% fewer admissions dur-
ing the period October to December 2020 compared to 
the mean number in the same months for 2016–2019. 
The impact was not equally distributed across PICU 
activity: for example, there was a greater reduction in 
unplanned (20%) than planned admissions (15%) in 
2020 compared with 2016–2019. A sharp reduction in 
admissions was observed in March 2020 with the nadir 
of PICU admissions occurring in April 2020 (Fig.  1). 
This was followed by a slow progressive increase in 
the number of admissions over the next few months. 
Notably, however, the typical winter peak in PICU 
admissions observed in 2016–2019 did not occur in 
2020 (Fig.  2). Age–sex adjusted prevalence per year 
of unplanned PICU admissions fell from 79.7 (2016–
2019) to 63.1 per 100,000 in 2020. Some variation in 
unplanned admissions was observed between coun-
tries in both 2020 (range 37.8 in NI to 68.3 in Scotland) 
and the 2016–2019 period: (range 74.7 in ROI to 91.5 
in NI) with the reduction in prevalence ranging from 
14.0 admissions per 100,000 in ROI to 53.7 admissions 
per 100,000 in NI.
Respiratory
A large proportion of the difference in number of PICU 
admissions was accounted for by the respiratory diag-
nostic group comprising 68% of difference in PICU 
admissions in 2020 with 2518 fewer respiratory admis-
sions (Fig.  2) compared with the mean for 2016–2019. 
Unsurprisingly this was mainly apparent in the young-
est admissions: infants < 12 months of age saw a relative 
reduction of 45% in 2020 compared with 2016–2019 
(1627 admissions in 2020 vs. a mean of 2964 admissions 
in 2016–2019) with a similar relative reduction seen in 
1–4 year olds (44%, 1020 admissions in 2020 vs. mean of 
1814 admissions in 2016–2019). The greatest reduction 
in respiratory admissions was for bronchiolitis with a rel-
ative reduction of 60% in admissions in 2020 compared 
with 2016–2019 (726 vs. mean of 1820). In particular, 
there were only 195 admissions for bronchiolitis between 
October and December 2020 compared with annual 
average of 1068 in same time period of 2016–2019, repre-
senting an 82% reduction.
Trauma
In contrast to this 40% reduction in respiratory admis-
sions in 2020 compared with respiratory admissions 
during 2016–2019, there was only a 6% relative reduc-
tion in trauma-related admissions observed during the 
pandemic.
Fig. 1 Boxplot of monthly PICU bed activity during the study period
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DKA
In 2020, there were 261 PICU admissions for DKA 
accounting for 1.5% of all admissions compared to a mean 
of 142 per year (ranging from 123 to 188) in the years 
2016–2019 (Fig.  3; Table  1), accounting for 0.7% of all 
admissions. Median (IQR) base-deficit of DKA patients 
at PICU admission during 2020 was 23 (16.6–26.5) com-
pared to 22.5 (16.9–26.9) in 2016–2019. Median PICU 
length of stay for DKA admissions in 2020 (1.3 [0.8–2.2] 
days) was similar to 2016–2019 (1.2 [0.8–2.1] days).
COVID‑19/PIMS‑TS
While there was a major impact of the pandemic on 
the overall numbers of admissions for PICU, the actual 
numbers of admissions of patients with COVID-19 
and/or PIMS-TS only totalled 410 (2.4%) in 2020 with 
the highest numbers in April and May (77 and 106 
admissions, respectively). This reflected the general 
population pandemic peaks for the UK.
Fig. 2 Admission trends in different primary diagnostic categories during the study period
Fig. 3 Control chart showing special cause variation in DKA admissions in PICU
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Post‑operative admissions
There were 1271 fewer planned post-operative admis-
sions to PICU in 2020 compared to the 2016–2019: mean 
6633 versus 7904 (range 7763–7976). The main constitu-
ents of this reduction comprised admissions following 
non-cardiac surgery (726, 57.1%) and admissions fol-
lowing cardiac surgery (507, 39.9%) compared with the 
2016–2019 average. PICU admissions after elective liver 
transplant remained stable with only a 0.5% reduction 
in activity through 2020 compared with the 2016–2019 
average.
PICU interventions
The proportion of admissions requiring invasive mechan-
ical ventilation on any day of PICU admission in 2020 
was statistically significantly lower than in 2016–2019 
with a decrease of 2.8% (95% CI 2.0–3.6%). Although the 
absolute numbers were lower in 2020, the proportion 
of admissions requiring the highest level of PICU inter-
ventions such as inhaled nitric oxide, continuous veno-
venous haemofiltration (CVVH) and extracorporeal life 
support (ECLS) remained constant throughout both time 
periods.
Outcomes
The PICU length of stay in 2020 was similar to the pre-
pandemic period: median length of stay (LOS) 2.3 (1.0–
5.7) days in 2020 versus 2.4 (1.0–5.5) days in 2016–2019. 
The in-PICU mortality rate in 2020 (3.6%) was similar 
to the previous years (3.4%). This was confirmed using a 
multilevel logistic regression model adjusting for PIM3-
predicted probability of death (OR 1.00 [0.91–1.11, 
p = 0.93]). However, given the reduction in the number 
of PICU admissions during 2020, this resulted in a lower 
absolute number of child deaths compared to the mean 
number of deaths per year in 2016–2019 (605 in 2020 vs. 
711 in 2016–2019). Of note, the in-PICU mortality rate 
for respiratory admissions was similar between the study 
periods [1.9% (2020) vs. 2.2% (2016–2019)], with an odds 
ratio of adjusted in-PICU mortality of 0.82 [0.63–1.06, 
p = 0.13].
Discussion
During 2020, there were approximately 3700 fewer 
admissions, 36,000 fewer bed-days, and 100 fewer child 
deaths in PICU compared to the 2016–2019 average. 
There was a reduction in age–sex adjusted prevalence 
of unplanned PICU admission of 17 per 100,000 popu-
lation in 2020 relative to the earlier period. The reduc-
tion in respiratory disease (in particular bronchiolitis) 
was the major contributor to the decrease in unplanned 
PICU admissions during 2020 with a striking absence 
of the expected winter peak. Conversely, there were 
significantly more admissions of patients with DKA com-
pared to previous years. However, we did not observe an 
increase in morbidity or severity of illness using proxy 
measures such as probability of death using PIM3, length 
of PICU stay, advanced level of interventions and in-
PICU mortality rates.
The virtual PICU systems (VPS) in the USA reported 
a 32% reduction in PICU admissions during April–June 
2020 compared with 2017–2019 average admission 
figures for that quarter [7]. However, data from July–
December 2020 were not reported. We observed an iden-
tical 32% reduction in PICU admissions during the same 
time period, followed by 12% and 20% reductions in July–
September and October–December, respectively. PICU 
bed-days for admissions between October and December 
2020 in this report were 38% lower than the comparable 
pre-pandemic period because of the striking absence of 
a winter peak. The VPS report observed that admission 
numbers for the time period between January and March 
2020 were comparable to that of the previous years. 
However, we report a 7% reduction during the same time 
period relative to 2016–2019. The first cases of COVID-
19 were reported in January 2020 in the UK, and in Feb-
ruary 2020 in the RoI. Lockdown rules were imposed in 
the UK and RoI in the last week of March 2020 [15]. The 
ensuing reduction in bed activity that occurred in March 
2020 is likely to have contributed to the difference. A 
report from Scotland that described data from their two 
PICUs, which are included in this dataset, also identified 
a similar reduction in PICU admissions with no substan-
tial evidence of harm [6].
Reduction in respiratory disease accounted for the 
majority of the difference in the number of PICU admis-
sions and bed-days. Reports from North and South 
America have also revealed a similar trend of a signifi-
cant reduction of respiratory viral illnesses [7, 8]. The 
reasons are not entirely clear, although it may be related 
to the effectiveness of population-based non-pharma-
cological public health interventions. Several public 
health interventions were widely adopted in the UK and 
RoI during 2020 [14, 15]. This included ‘stay-at-home 
orders’, social distancing measures, mobility restrictions, 
school closures, mask wearing and shielding of vulner-
able populations [14, 16]. Both the time periods with 
higher magnitude of reduction in PICU admissions and 
bed-days, i.e. April–June 2020 and October–Decem-
ber 2020, coincided with periods of national lockdown. 
Unlike April–June 2020, the stay-at-home orders were 
not accompanied by a national school closure during 
October–December 2020. However, there was a require-
ment for face covering, social distancing measures, better 
access to SARS-CoV-2 testing and isolation of sympto-
matic subjects. The direct impact of these public health 
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interventions on COVID-19 has been reported [17, 18]. 
The 2003 epidemic of severe acute respiratory virus 
(SARS) triggered an examination of the effectiveness of 
non-pharmacological interventions on other illnesses. 
There is some evidence to support the effectiveness of 
some of the strategies used during this pandemic in the 
spread of respiratory infections including influenza, 
upper respiratory tract infections, and respiratory syncy-
tial virus infections, with a notable effect in reducing sec-
ondary attack rates in young children [19, 20]. Given the 
reduction in the absolute number of child deaths in PICU 
reported in this study, as well as from other parts of the 
world [21, 22], it remains to be seen whether some of the 
public health measures such as social distancing, wear-
ing masks or face coverings and frequent hand-washing 
continue to be widely adopted and remain sustained in 
the community. It is as yet unclear how the low levels of 
exposure to respiratory pathogens among infants and 
children during the pandemic will impact on future sea-
sonal and inter-seasonal respiratory viral surges. How-
ever, reports from Australia and elsewhere have raised 
this as a concern [23].
An increase in DKA referrals was reported by one of 
the regional UK PICU transport services during the 
COVID-19 pandemic compared with previous years, 
despite a substantial reduction in overall referrals to the 
service [24]. A study from the USA also reported a signif-
icant increase in patients with diabetes mellitus in PICU, 
but perhaps not necessarily with DKA [7], while a report 
from across Canada identified a significant increase in 
both DKA and severe DKA presentations in new Type 
1 diabetes mellitus [25]. Our analysis confirms the trend 
of a recent increase in PICU admissions for DKA. How-
ever, it is unclear whether an association exists with 
SARS-CoV-2 infection, given that the increase in DKA 
admissions was first observed prior to the pandemic 
(October–December 2019), but remained sustained at 
higher levels during the pandemic. Delayed diagnosis of 
diabetes resulting in presentation as a DKA admission 
was raised as a concern [26]. Comparisons of base defi-
cit and length of stay of PICU admissions for DKA did 
not support an increase in severity of illness at PICU 
admission.
The VPS report described an increase in the propor-
tion of trauma-related PICU admissions from 6.8% dur-
ing April–June 2017–2019 to 9% of PICU admissions 
over the period April–June 2020, while the absolute 
numbers during this period in 2020 were lower than the 
previous years [7]. Our observations were similar, but 
with a smaller non-significant increase from 2% of all 
PICU admissions in 2016–2019 to 2.3% in 2020. Again, 
there were fewer absolute numbers of patients admitted 
with trauma during 2020 and the differences are perhaps 
explained by a larger reduction in the non-trauma admis-
sions, such as respiratory infections.
Altered health seeking behaviour resulting in delayed 
presentation has been implicated as a potential concern 
during the pandemic [26]. Comparison of severity of ill-
ness on presentation to PICU during 2020 with data from 
the period 2016–2019, drawn from the analysis of the 
probability of death based on PIM3 calculations, PICU 
length of stay, need for advanced levels of critical care 
support, such as inhaled nitric oxide, renal replacement 
therapy or extracorporeal life support, did not reveal any 
evidence to support the hypothesis of delayed access to 
care. Analysis of data from several UK emergency depart-
ments confirms that delayed presentations were indeed 
rare [27]. The results of this study support this conclu-
sion, although timely and appropriate public health mes-
sages from relevant public health authorities may have 
helped.
Overall COVID-19 and PIMS-TS accounted for fewer 
than 500 PICU admissions in 2020. Just under half of 
all reported cases of PIMS-TS in the UK and ROI were 
admitted to PICU and we have established that these 
were predominantly for vasoactive medications rather 
than respiratory support [2, 28]. By contrast, COVID-19 
in adults resulted in excess of 25,000 critical care admis-
sions in ICUs in England, Wales and Northern Ireland 
in 2020 [29]. Some of the PICU capacity freed up by the 
reduced number of childhood admissions were then uti-
lised to provide critical care for the adults [5, 30]. Moreo-
ver, paediatric critical care staff were also redeployed in 
adult ICUs. This demonstrated an efficient and collabo-
rative approach which was sensitive to the needs of the 
population, while preserving adequate paediatric critical 
care capacity.
Reduction in elective surgical activity was implemented 
in many parts of the world to free up capacity to cope 
with surge in COVID-19 related admissions. Several pae-
diatric cardiac surgery programmes deferred most, if not 
all, elective activity [31]. This report identified the impact 
on elective non-cardiac surgery activity, which was 
higher than the observed reduction in cardiac surgical 
activity. These numbers provide information about the 
anticipated need for additional PICU capacity when elec-
tive surgeries resume. In addition, differences observed 
between different surgical programmes and between dif-
ferent regions may provide important information for 
future pandemic planning.
We observed important differences compared to the 
US report from VPS. We observed no significant differ-
ences in probability of death using PIM3, or mortality 
during 2020, as opposed to a small but statistically signif-
icant increase in median PIM2 and mortality in the VPS 
dataset. The reasons for this are not entirely clear though 
Page 8 of 9Kanthimathinathan et al. Crit Care          (2021) 25:399 
this UK and RoI report analysed the whole of 2020 data 
and is population-based.
This study reports on a well-established registry cover-
ing the whole of the UK and the RoI. Data are validated 
and known to be of high quality [9]. This dataset has 
established definitions and reports annually on numbers 
of admissions, severity indicators, specific diagnoses of 
interest and intervention related information as well as 
mortality. As a result we can be confident that the data 
we present reflect the front line experience of paediatric 
critical illness in the UK in 2020 and preceding years. We 
were able to present granular information presented in 
the form of monthly, as well as quarterly figures showing 
the evolution of the impact of the pandemic on PICU.
Nevertheless this report does have some limitations. 
Diagnostic category assignment is based on primary 
diagnosis as reported by clinicians in the participating 
units and some inconsistency within and between par-
ticipating units may be present. Given that this data only 
represents designated PICUs, this data cannot be extrap-
olated to non-PICU hospitalisations or child deaths. 
A recently published study of national child mortality 
database in England reported that the all-cause mortal-
ity in children in 2020 (2264 deaths) was slightly lower 
that 2019 (2498 deaths) with a relative risk of 0.92 (0.87–
0.98), p = 0.009) [32]. Nevertheless, comparative analysis 
of wider preceding time periods as well as from other 
countries is required before confirmation of this effect. 
This study does not include any other measures of health 
impact on children such as primary care attendances, 
hospitalisation, immunisation and other wider meas-
ures such as education, nutrition, fitness, poverty and 
mental health. These are also required to build an over-
all assessment to consider the risks and benefits posed 
by any large public health intervention in the future. An 
interrupted time series or regression discontinuity design 
analyses may be required to specifically analyse asso-
ciation between periods of the public health interven-
tion measures and impact on PICU case-mix, outcomes 
during the pandemic. However, the timing and nature 
of interventions were variable at different countries. A 
regional approach was also pursued within some coun-
tries and these introduce significant barriers. As such 
our study merely describes the association between pan-
demic-related variables and the PICU case-mix, outcome 
differences, rather than test for causation.
Conclusions
During 2020 we found a significant reduction in age–
sex adjusted prevalence of unplanned PICU admissions, 
the number of PICU admissions, particularly second-
ary to respiratory diseases, and fewer child deaths in 
PICU. While it is possible that these may point towards 
a beneficial impact of population-based public health 
interventions during the COVID-19 pandemic, wider 
societal impact on physical and mental health of chil-
dren are unclear. However, this could be considered as 
useful information, at least in part, to generate a public 
discourse related to the population costs and benefits 
of continuing adoption of public health interventions in 
some form or other to relieve annual winter pressures on 
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